Niagen Bioscience (NAGE) Divestments (2013 - 2026)

Niagen Bioscience (NAGE) reported Divestments of $5.8 million for Q1 2026, up 215.1% quarter-over-quarter from $1.8 million in Q1 2015.

Niagen Bioscience (NAGE) Divestments (2013 - 2026) Analysis & Trends

Niagen Bioscience (NAGE) has 3 years of Divestments data on file, last reported at $5.8 million in Q1 2026.

Divestments for Q1 2026 came in at $5.8 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $8.1 million (changed N/A YoY), and the FY2015 annual result was $1.8 million, changed N/A from the prior year.
Divestments grew to $5.8 million in Q1 2026 per NAGE's latest filing, from $1.8 million in the prior quarter.
Over five years, Divestments peaked at $5.8 million in Q1 2026 and troughed at $5.8 million in Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Divestments (Qtr)
1	Alterity Therapeutics	788,338.31 Bn	788,338.28 Bn	-	-
2	Belite Bio	56,560.00 Bn	56,560.00 Bn	-	-
3	Quantum Biopharma	17,329.30 Bn	17,329.30 Bn	-	-
4	Legend Biotech	3,341.00 Bn	3,340.71 Bn	242.10 Mn	-
5	Akari Therapeutics	1,727.91 Bn	1,727.91 Bn	-	-
6	Evaxion A	1,536.68 Bn	1,536.67 Bn	-	-
7	Psyence Biomedical	238.34 Bn	238.33 Bn	-	-
8	Vertex Pharmaceuticals	113.42 Bn	106.17 Bn	2.59 Bn	-
9	Abivax	95.45 Bn	95.45 Bn	-	-
10	Niagen Bioscience	280.11 Mn	213.56 Mn	19.98 Mn	5.80 Mn

Download Data